ARRAIL Group (06639) announced that for the six months ending September 30, 2025, the Group expects to achieve a pre-tax profit of no less than RMB 20 million, compared to approximately RMB 7.4 million for the same period in 2024. The anticipated increase in profit is primarily attributed to: operational improvements driven by the Group's AI-powered clinical and business management systems; sustained recovery in patient demand and service volume; and the Group's stringent cost-reduction and efficiency-enhancement initiatives.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments